Researchers Working to Create Universal Flu Vaccine

It's National Influenza Vaccination Week. Cleveland Clinic researchers are working to create a universal flu vaccine, which wouldn't need to be updated annually like it does now.

Media Downloads

CCNS health and medical content is consumer-friendly, professional broadcast quality (available in HD), and available to media outlets each day.

Additional Assets

*Email us for video download password Content is property of Cleveland Clinic and for news media use only.

Media Contact

We're available to shoot custom interviews & b-roll for media outlets upon request.

CLEVELAND – Every year, a new flu shot is created based on different factors, like which types of the virus are expected to be the most common. 

But, that could change in the future. 

Cleveland Clinic researchers are working on a flu vaccine that wouldn’t need to be modified annually.  
“The development of next generation vaccine, the goal has been to come up with a vaccine strategy that work against all strains that circulate now, as well as circulate in the future, strains that don’t even yet exist,” explained Ted Ross, PhD, Global Director of Vaccine Development at Cleveland Clinic.
Dr. Ross said by making a vaccine that covers all the flu strains, people would have immunity both now and in the future. 

It would also eliminate annual flu shots.
So rather than having to get a shot every year, he said you would only need to get one every couple of years. 

That convenience may also encourage more people to get vaccinated.  

Dr. Ross notes that the vaccine will have to be updated once in a while and won’t be able to eradicate the flu completely. 

That’s because the virus is present in animals as well.  
“The viruses that have been eradicated or close to eradications for humans are strains of viruses that only circulate in people,” he said. “For example, smallpox. Smallpox was only a human pathogen. As long as there is a zoonotic reservoir out there, we’ll probably never get rid of flu.” 
Dr. Ross said research for this vaccine has been in the works for 20 years. 

Clinical trials will begin at the end of 2024.  

For Journalists Only

Sign up below to be added to our Daily Health Stories distribution list.

For more information on medical conditions and diseases, visit our Health Library.